Cell-free biocatalytic synthesis of n-trans-caffeoyltyramine (NCT) and derivatives thereof

WO2026236497A1PCT designated stage Publication Date: 2026-11-12EXOZYMES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/US2026/027112
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2026-05-07
Publication Date
2026-11-12

Smart Images

  • Figure US2026027112_12112026_PF_FP_ABST
    Figure US2026027112_12112026_PF_FP_ABST
Patent Text Reader

Abstract

The present disclosure relates to multi-enzyme, cell-free biosynthetic systems for the production of N-trans-caffeoyltyramine ("NCT") or NCT derivatives, utilizing natural and engineered polypeptides exhibiting transferase, ligase, decarboxylase, and kinase activities. Engineered variants of the enzymes used in the process with improved thermostability, solvent tolerance, and catalytic efficiency also are disclosed. Methods for synthesizing N-trans-caffeoyltyramine ("NCT") or NCT derivative utilizing additives and compositions comprising synthesized products with optional trace components are also provided. These systems are applicable for the synthesis of compounds used in pharmaceutical, nutraceutical, cosmetic, food, and beverage formulations.
Need to check novelty before this filing date? Find Prior Art